Corbus Pharmaceuticals Holdings, Inc. (CRBP) — Institutional Holders, Q2 2026 (page 2)
107 institutional investment managers reported a CRBP position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $129.1M. Every filer is listed below, ranked by position value, 100 per page; this page shows ranks 101 to 107. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
CRBP 13F holders ranked 101–107 of 107
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 101 | HARBOUR INVESTMENTS#101 · 13 sh | 13 | $122.00 | 0.00% | 0.0% |
| 102 | NewEdge Advisors#102 · 8 sh | 8 | $75.00 | 0.00% | New |
| 103 | Cassaday & Wealth Management#103 · 6 sh | 6 | $57.00 | 0.00% | -50.0% |
| 104 | EASTERN BANK#104 · 6 sh | 6 | $56.00 | — | 0.0% |
| 105 | SRS Capital Advisors#105 · 3 sh | 3 | $28.00 | 0.00% | 0.0% |
| 106 | BFSG#106 · 1 sh | 1 | $10.00 | 0.00% | 0.0% |
| 107 | FIFTH THIRD BANCORP#107 · 1 sh | 1 | $9.00 | 0.00% | 0.0% |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.